Thermo Fisher Scientific Inc. TMO
679.77 USD -26.39 (-3.74%)
Nov 5, 2026, 2:05 PM EST
689.13 Day range 708.93
435.27 52-week range 712.17
- YTD
- +17.31%
- 1 year
- +19.75%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 44.56B | 42.88B | 42.86B | 44.91B | 39.21B | |
| 18.24B | 17.70B | 17.10B | 18.97B | 19.64B | |
| 7.75B | 7.34B | 6.86B | 8.39B | 10.03B | |
| 6.70B | 6.33B | 6.00B | 6.95B | 7.72B | |
| 17.74 | 16.53 | 15.45 | 17.63 | 19.46 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.85B | 4.01B | 8.08B | 8.52B | 4.48B | |
| 110.34B | 97.32B | 98.73B | 97.15B | 95.12B | |
| 56.93B | 47.77B | 52.00B | 53.12B | 54.27B | |
| 39.38B | 31.27B | 34.92B | 34.49B | 34.87B | |
| 53.41B | 49.58B | 46.73B | 43.98B | 40.79B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.82B | 8.67B | 8.41B | 9.15B | 9.31B | |
| -4.05B | -5.84B | -5.14B | -2.16B | -21.93B | |
| 1.80B | -6.79B | -3.62B | -2.81B | 6.58B | |
| -1.48B | -1.34B | -1.39B | -2.22B | -2.50B | |
| 5.84B | -4.06B | -440.00M | 4.05B | -5.84B |